16th Annual Scientific Meeting - Heart Failure Society of America

Sept. 11
Tuesday
PM
ORAL ABSTRACT SESSION
Tuesday, September 11
12:30-1:30 PM
Ballroom 6A
ORAL ABSTRACT SESSION
Tuesday, September 11
12:30-1:30 PM
Ballroom 6A
Sept. 11
Tuesday
PM
Rapid Fire Abstracts
Rapid Fire Abstracts (cont.)
Tuesday
Moderators: Arthur M. Feldman, Philadelphia, PA
Carl V. Leier, Columbus, OH
12:30* Results of the RISK Trial: Renal Function and 184
Female Gender Are Strongly Associated with
Early Response to Cardiac Resynchronization
Therapy
Alaa A. Shalaby, John Gorcsan, Gregg Fonarow, Jagmeet
Singh, Malcolm Bersohn, Jasmina Halilovic, Manish Gupta,
Ali Sonel, Samir Saba, William Abraham, Alan Kadish;
University of Pittsburgh, PA; UCLA, Los Angeles, CA;
Massachusetts General Hospital, Boston, MA; St. Jude
Medical, Sunnyvale/Sylmar, CA; The Ohio State University,
Columbus, OH; Touro College, New York, NY
12:35* The Impact of Isolated Diastolic Dysfunction 157
on Atrial Fibrillation Recurrence after Catheter
Ablation
Rosita Zakeri, Jia H. Wu, David O. Hodge, Kristi H.
Monahan, Yong-Mei Cha, Douglas L. Packer, Margaret
M. Redfield; Division of Cardiovascular Diseases, Mayo
Clinic, Rochester, MN
12:40* Tetrahydrobiopterin Improves Diastolic 018
Heart Failure by Increasing Myofilament
Calcium Sensitivity
Euy-Myoung Jeong, Michelle M. Monasky, Lianzhi Gu,
Domenico M. Taglieri, Bindiya G. Patel, Qiongying Wang,
Harvey Lardin, Ian Greener, R. John Solaro, Samuel C.
Dudley, Jr; Section of Cardiology, College of Medicine,
University of Illinois at Chicago, IL; Department of
Physiology and Biophysics and Center for Cardiovascular
Research, University of Illinois at Chicago, IL
12:45* Activation of Pulmonary Arterial Endothelium 016
in Heart Failure with Preserved Ejection Fraction
Induced Pulmonary Hypertension Similar to
Pulmonary Arterial Hypertension
Jason N. Salamon, Jeremy Mazurek, Ronald Zolty; Jacobi
Medical Center/Albert Einstein College of Medicine,
Bronx, NY; Cardiology, Montefiore Medical Center, Albert
Einstein College of Medicine, Bronx, NY
12:50* Therapy with a DPP-4 Inhibitor Increases 026
Myocardial Glucose Uptake in Nonischemic
Cardiomyopathy
Ronald M. Witteles, Khun V. Keu, Andrew Quon, Homa
Tavana, Michael B. Fowler; Stanford University School of
Medicine, Stanford, CA
12:55* Urokinase Induces Pro-Fibrotic/M2 Phenotype 082
in Cardiac Macrophages
Laura Malchodi, Deri Helterline, Jessica Meznarich,
April Stempien-Otero; Medicine Division of Cardiology,
University of Washington, Seattle, WA; Pediatrics,
University of Utah, Salt Lake City, UT
(continued next page)
*3 minutes to present, 2 minute discussion
1:00* Incidence, Predictors and Outcomes Related 181
to Hypo and Hyperkalemia in Severe Heart
Failure Patients Treated with an
Aldosterone Antagonist
Orly Vardeny, DongHong Wu, Brian Claggett, Akshay
Desai, Patrick Rossignol, Faiez Zannad, Bertram Pitt5,
Scott D. Solomon; University of Wisconsin, Madison, WI;
Brigham and Women’s Hospital, Boston, MA; INSERM,
Centre d’Investigations Cliniques-950 and Nancy-
Universite, Nancy, France; University of Michigan School
of Medicine, Ann Arbor, MI
1:05* Inpatient Initiation and Target Dosing of ACE 298
Inhibitors and Beta-Blockers in Children with
Heart Failure
Jack F. Price, BreAnn N. Taylor, Aamir Jeewa, William J.
Dreyer, Susan W. Denfield, Antonio G. Cabrera, Brady S.
Moffett; Pediatric Cardiology, Baylor College of Medicine,
Houston, TX; Pharmacy, Texas Children’s Hospital,
Houston, TX
1:10* Adverse In-Hospital Outcomes by Systolic 289
Blood Pressure at Admission in Patients
Hospitalized with Acute Heart Failure
Syndromes − Data from RO AHFS Registry
Ovidiu Chioncel, Dragos Vinereanu, Serban Bubenek,
Andrew Ambrosy, Cezar Macarie, Mihai Gheorghiade;
Institute of Emergency for Cardiovascular Diseases “Prof.
Dr. C.C. Iliescu”, Bucharest, Romania; Universitary
Emergency Hospital, Bucharest, Romania; Department
of Medicine, Stanford University School of Medicine,
Stanford, CA; Center for Cardiovascular Innovation,
Northwestern University, Feinberg School of Medicine,
Chicago, IL
1:15* The Timing of Hemoconcentration During 230
Treatment of Decompensated Heart Failure
Influences Subsequent Survival
Meredith A. Brisco, Steve Coca, Stephen Kimmel, Jeffrey
M. Testani; Department of Medicine, Cardiovascular
Division, University of Pennsylvania School of Medicine,
Philadelphia, PA; Department of Medicine, Yale University
School of Medicine, New Haven, CT
1:20* Stimulation of β2 Adrenergic Receptors
Clears Lung Fluid in Patients with Heart Failure
024
Bryan J. Taylor, Maile L. Ceridon, Eric M. Snyder, Bruce
D. Johnson; Cardiovascular Diseases, Mayo Clinic,
Rochester, MN; Pharmacy Practice and Science, University
of Arizona, Tucson, AZ
1:25* Obesity Paradox Does Not Apply to
Acute Heart Failure
226
Maya Guglin, Ren Chen; Cardiology, University of South
Florida, Tampa, FL
*3 minutes to present, 2 minute discussion
Learning Objective: Discuss findings from recent research
in HF and their implications for heart failure research and
treatment.
Tuesday
104 105